Lupin surges on receiving FDA approval for generic Klor-Con Extended-Release Tablets

11 Aug 2016 Evaluate

Lupin is currently trading at Rs 1564.00, up by 18.95 points or 1.23% from its previous closing of Rs 1545.05 on the BSE.

The scrip opened at Rs. 1564.00 and has touched a high and low of Rs. 1569.00 and Rs. 1551.00 respectively. So far 42965 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127.00 on 06-Oct-2015 and a 52 week low of Rs. 1294.05 on 29-Mar-2016.

Last one week high and low of the scrip stood at Rs 1729.50 and Rs 1540.10 respectively. The current market cap of the company is Rs 70519.91 crore.

The promoters holding in the company stood at 46.76%, while Institutions and Non-Institutions held 42.40% and 10.83% respectively.

Lupin’s US subsidiary, Gavis Pharmaceuticals LLC., USA (collectively Lupin) has received final approval for its Potassium Chloride Extended-Release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg) from the United States Food and Drug Administration (FDA) to market a generic equivalent of Upsher-Smith Labs Klor-Con Extended-Release Tablets, 8 mEq and 10 mEq. Klor-Con Extended-Release Tablets, 8 mEq and 10 mEq had US sales of $101.3 million, as per IMS MAT June 2016.

Lupin’s Potassium Chloride Extended-Release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg) are the AB rated generic equivalent of Upsher-Smith Labs Klor-Con Extended-Release Tablets, 8 mEq and 10 mEq. It is an electrolyte replenisher indicated for - the therapeutic use of patients with hypokalemia, with or without metabolic alkalosis; in digitalis intoxication; and in patients with hypokalemic familial periodic paralysis. The prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2119.50 -31.55 (-1.47%)
01-Feb-2026 13:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1613.50
Dr. Reddys Lab 1220.00
Cipla 1315.25
Zydus Lifesciences 883.80
Lupin 2119.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×